AVNS (Avanos Medical, Inc.) Stock Analysis - SEC Filings

Avanos Medical, Inc. (AVNS) is a publicly traded Healthcare sector company. As of May 21, 2026, AVNS trades at $24.74 with a market cap of $1.16B and a P/E ratio of -2.90. AVNS moved -0.04% today. Year to date, AVNS is +118.74%; over the trailing twelve months it is +88.86%. Its 52-week range spans $9.30 to $24.91. Rallies surfaces AVNS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find AVNS SEC filings?

Rallies organizes AVNS SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

AVNS Key Metrics

Key financial metrics for AVNS
MetricValue
Price$24.74
Market Cap$1.16B
P/E Ratio-2.90
EPS$-8.53
Dividend Yield0.00%
52-Week High$24.91
52-Week Low$9.30
Volume0
Avg Volume0
Revenue (TTM)$687.80M
Net Income$-392.10M
Gross Margin55.44%

Latest AVNS News

Recent AVNS Insider Trades

  • Holbrook Kerr sold 13.83K (~$152.17K) on Nov 18, 2025.
  • Holbrook Kerr sold 100 (~$1.10K) on Nov 18, 2025.
  • Holbrook Kerr sold 761 (~$8.38K) on Nov 18, 2025.

AVNS Analyst Consensus

AVNS analyst coverage data. Average price target: $0.00.

Common questions about AVNS

Where can I find AVNS SEC filings?
Rallies organizes AVNS SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show AVNS 10-K and 10-Q filings?
Rallies organizes AVNS SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is AVNS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for AVNS. It does not provide personalized investment advice.
AVNS

AVNS